Physician profile
Jack M Mclendon
NPI 1588750566
$2,099.78
in general payments reported to CMS, 2019-2025
11 companies · $14.50 in 2025
The $14.50 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $986 · 2020: $333 · 2021: $459 · 2022: $307 · 2025: $14.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,244.58 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $325.58 | 2019-2022 | |
| Amgen INC. | $139.06 | 2019-2025 | Evenity |
| Amarin Pharma, INC. | $129.65 | 2019-2020 | |
| Lilly USA, LLC | $95.44 | 2019-2020 | |
| Roche Diagnostics Corporation | $50.00 | 2019 | |
| Portola Pharmaceuticals, LLC | $48.32 | 2019 | |
| Abbvie INC. | $32.52 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $11.85 | 2019 | |
| Novartis Pharmaceuticals Corporation | $11.74 | 2019 | |
| Pfizer INC. | $11.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Mclendon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.